Proteomic Analysis in Paediatric Diabetes Type 1 (PAPD) (PAPD)
Targeted Proteomic Analysis in the Plasma of Children With Diabetes Type 1 and Its Association With Peripheral Diabetic Neuropathy
Sponsor: Aristotle University Of Thessaloniki
A observational or N/A phase clinical study on Diabetes Type 1 and Diabetic Peripheral Neuropathy, this trial is actively recruiting participants. The trial is conducted by Aristotle University Of Thessaloniki and has accumulated 9 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Aug 2024 — Sep 2024 [monthly]
Recruiting
-
Jul 2024 — Aug 2024 [monthly]
Recruiting
-
Aug 2023 — Jul 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Dec 2022 — Aug 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
-
Jan 2021 — Dec 2021 [monthly]
Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Recruiting
-
Mar 2020 — Nov 2020 [monthly]
Recruiting
First recorded
Nov 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aristotle University Of Thessaloniki
For direct contact, visit the study record on ClinicalTrials.gov .